Search | IOVS | ARVO Journals

Showing 1 – 20 of 31

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

A role of Th1/17 cells migrating across the blood-retinal-barrier in experimental autoimmune uveitis

Yi hsing Chen; Malihe Eskandarpour; Mahid Chaudhry; Xiaozhe Zhang; Susan Lightman; Virginia L Calder

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):785. doi:

ARVO Annual Meeting Abstract July 2018

Cross-sectional study of sarcoid uveitis diagnostic criteria, disease control and long-term visual outcome

Xia Ni Wu; Rachael Niederer; Lazha Sharief; Susan Lightman; Oren Tomkins-Netzer

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4193. doi:

ARVO Annual Meeting Abstract July 2018

Causes of vision loss and clinical outcomes over an 18 year period in patients with Vogt–Koyanagi–Harada Disease

Sophia Zagora; Yi-Hsing Chen; Susan Lightman; Oren Tomkins-Netzer

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4200. doi:

ARVO Annual Meeting Abstract July 2018

Comparison of anatomical and functional outcomes of treatment with bevacizumab and ranibizumab injections in eyes with myopic choroidal neovascularization (mCNV)

Malgorzata Woronkowicz; Susan Lightman; Robin Hamilton; Sophia Zagora; Oren Tomkins-Netzer

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4745. doi:

ARVO Annual Meeting Abstract July 2018

Relevance and Validation of Optical Coherence Tomography based on Volumetric Measures in Age-Related Macular Degeneration

Ali Lamin; Jonathan D Oakley; Adam M Dubis; Susan Lightman; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3231. doi:

ARVO Annual Meeting Abstract July 2018

Deep learning for prediction of AMD progression

Daniel B Russakoff; Ali Lamin; Jonathan D Oakley; Adam M Dubis; Susan Lightman; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1717. doi:

ARVO Annual Meeting Abstract July 2018

Prospective study of the morphologic and functional parameter changes post treatment of macular oedema associated with different retinal disorders

Lazha Sharief; Yi-Hsing Chen; Susan Lightman; Oren Tomkins-Netzer

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):392. doi:

ARVO Annual Meeting Abstract July 2018

Tumor necrosis factor inhibitors improve inflammatory control in eyes with refractory non-infectious uveitis.

Ahmed Al-Janabi; Amgad El Nokrashy; Lazha Sharief; Susan Lightman; Oren Tomkins-Netzer

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):407. doi:

ARVO Annual Meeting Abstract July 2018

Anti-tuberculosis treatment reduces the risk of disease recurrence among eye with latent tuberculosis-related uveitis

Oren Tomkins-Netzer; Belinda Leong; Xiaozhe Zhang; Susan Lightman; Peter J McCluskey

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1141. doi:

ARVO Annual Meeting Abstract July 2018

Clinical Remission of Sight-threatening Uveitits is Characterised by an Upregulation of Peripheral TIGIT + Treg and an Increased Ratio of T reg to T-bet + T cells

Rachel J Healy; Elewys Gemma Hearne; Rose Gilbert; Xiaozhe Zhang; Oren Tomkins-Netzer; Michael Ehrenstein; Virginia Calder; Susan Lightman

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2520. doi:

ARVO Annual Meeting Abstract July 2018

CD19 + CD24 hi CD38 hi B regulatory cell levels correlate with disease remission in patients with non-infectious uveitis

Xiaozhe Zhang; Rose Gilbert; Robert Sampson; Oren Tomkins-Netzer; Virginia Calder; Susan Lightman

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2523. doi:

ARVO Annual Meeting Abstract July 2018

Effects of α4β1 Integrin Inhibitor on Leucocyte Subset Migration in Experimental Autoimmune Uveitis

Yi hsing Chen; Malihe Eskandarpour; Grazyna Galatowicz; Mahid Chaudhry; Xiaozhe Zhang; Susan Lightman; Virginia Calder

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2541. doi:

ARVO Annual Meeting Abstract July 2018

Evaluation of the visual outcome for patients treated for Inflammatory Choroidal Neovascularization in a Tertiary Referral Center in United Kingdom

Anastasia Tasiopoulou; Malgorzata Woronkowicz; Susan Lightman; Oren Tomkins-Netzer

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3158. doi:

ARVO Annual Meeting Abstract June 2017

Similar outcomes for oral and intravenous treatment of acute retinal necrosis

Julijana Baltinas; Susan Lightman; Peter J McCluskey; Oren Tomkins-Netzer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3611. doi:

ARVO Annual Meeting Abstract June 2017

Optical Coherence Tomography Angiography Assessment Of Choriocapillaris Ischemia In Ampiginous And Serpigenous Choroidits And Its Response To Treatment

Dilraj Singh Grewal; Sophia L Zagora; Susan Lightman; Oren Tomkins-Netzer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):500. doi:

ARVO Annual Meeting Abstract September 2016

Levels of corticosteroids positively correlate with IL-10+FoxP3 + CD25 + CD4 + T regulatory cells but not with CD4 + IL-17 + Th17 cells in Behçet’s Disease

Xiaozhe Zhang; David Yang; Grazyna Galatowicz; Susan Lightman; Virginia L Calder

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):494. doi:

ARVO Annual Meeting Abstract September 2016

TIGIT+ Tregs May Be Associated with Clinical Remission of Non-Infectious Uveitis

Rose Gilbert; Xiaozhe Zhang; Robert Sampson; Oren Tomkins-Netzer; Grazyna Galatowicz; Virginia L Calder; Susan Lightman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3313. doi:

ARVO Annual Meeting Abstract April 2014

Risk factors for reduced visual acuity in non-infectious intermediate, posterior, and panuveitis

Douglas A Jabs; Mark L Van Natta; Michael M Altaweel; James P Dunn; Susan Lightman; Jennifer E Thorne; Janet T Holbrook; John H Kempen; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6033. doi:

ARVO Annual Meeting Abstract April 2014

Visual acuity outcome of non-infectious intermediate, posterior, and panuveitis in the Multicenter Uveitis Steroid Treatment (MUST) Trial

John H Kempen; Mark L Van Natta; Michael M Altaweel; James P Dunn; Douglas A Jabs; Susan Lightman; Jennifer E Thorne; Janet T Holbrook; The Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6036. doi:

Clinical Trials July 2013

Vision-Related Functioning Outcomes of Dexamethasone Intravitreal Implant in Noninfectious Intermediate or Posterior Uveitis

PDF

Susan Lightman; Rubens Belfort, Jr.; Rupali K. Naik; Careen Lowder; C. Stephen Foster; Anne M. Rentz; Harry Cui; Scott M. Whitcup; Jonathan W. Kowalski; Dennis A. Revicki
TAGS: dexamethasone, implants, uveitis, posterior, vision, intravitreal implants
Invest. Ophthalmol. Vis. Sci.. 2013; 54(7):4864-4870. doi: https://doi.org/10.1167/iovs.12-10981

Includes: Supplemental Content

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

A role of Th1/17 cells migrating across the blood-retinal-barrier in experimental autoimmune uveitis

Cross-sectional study of sarcoid uveitis diagnostic criteria, disease control and long-term visual outcome

Causes of vision loss and clinical outcomes over an 18 year period in patients with Vogt–Koyanagi–Harada Disease

Comparison of anatomical and functional outcomes of treatment with bevacizumab and ranibizumab injections in eyes with myopic choroidal neovascularization (mCNV)

Relevance and Validation of Optical Coherence Tomography based on Volumetric Measures in Age-Related Macular Degeneration

Deep learning for prediction of AMD progression

Prospective study of the morphologic and functional parameter changes post treatment of macular oedema associated with different retinal disorders

Tumor necrosis factor inhibitors improve inflammatory control in eyes with refractory non-infectious uveitis.

Anti-tuberculosis treatment reduces the risk of disease recurrence among eye with latent tuberculosis-related uveitis

Clinical Remission of Sight-threatening Uveitits is Characterised by an Upregulation of Peripheral TIGIT + Treg and an Increased Ratio of T reg to T-bet + T cells

CD19 + CD24 hi CD38 hi B regulatory cell levels correlate with disease remission in patients with non-infectious uveitis

Effects of α4β1 Integrin Inhibitor on Leucocyte Subset Migration in Experimental Autoimmune Uveitis

Evaluation of the visual outcome for patients treated for Inflammatory Choroidal Neovascularization in a Tertiary Referral Center in United Kingdom

Similar outcomes for oral and intravenous treatment of acute retinal necrosis

Optical Coherence Tomography Angiography Assessment Of Choriocapillaris Ischemia In Ampiginous And Serpigenous Choroidits And Its Response To Treatment

Levels of corticosteroids positively correlate with IL-10+FoxP3 + CD25 + CD4 + T regulatory cells but not with CD4 + IL-17 + Th17 cells in Behçet’s Disease

TIGIT+ Tregs May Be Associated with Clinical Remission of Non-Infectious Uveitis

Risk factors for reduced visual acuity in non-infectious intermediate, posterior, and panuveitis

Visual acuity outcome of non-infectious intermediate, posterior, and panuveitis in the Multicenter Uveitis Steroid Treatment (MUST) Trial

Vision-Related Functioning Outcomes of Dexamethasone Intravitreal Implant in Noninfectious Intermediate or Posterior Uveitis

To View More...

You must be signed into an individual account to use this feature.